[1]
Santos, I.F., Pereira, S., McLeod, E., Guillermin, A.-L. and Chatzitheofilou, I. 2014. Economic Analysis of Rivaroxaban for the Treatment and Long-Term Prevention of Venous Thromboembolism in Portugal. Acta Médica Portuguesa. 27, 5 (Oct. 2014), 615–624. DOI:https://doi.org/10.20344/amp.5257.